We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+10.49%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.16%
AUM
$11.9B
AUM Growth
+$2.55B
(+27%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
15.19%
Top 10 Holdings %
Top 10 Hldgs %
28.34%
Holding
1,181
New
44
Increased
774
Reduced
301
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$294M |
| 2 |
Apple
AAPL
|
+$74.6M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$68.1M |
| 4 |
Tesla
TSLA
|
+$64.9M |
| 5 |
Microsoft
MSFT
|
+$51.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$12.3M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$8.37M |
| 3 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$7.53M |
| 4 |
ASML
ASML
|
+$7.05M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$6.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.81% |
| 2 | Financials | 13.96% |
| 3 | Healthcare | 11.37% |
| 4 | Energy | 7.72% |
| 5 | Consumer Discretionary | 3.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
iShares Global Clean Energy ETF
ICLN
$2.09B
| $3.98M | 0.03% |
200,621
-64,996
| -24% | -$1.28M |
|
427
Corning
GLW
$137B
| $3.97M | 0.03% |
124,431
+22,777
| +22% | +$739K |
|
428
Edwards Lifesciences
EW
$54B
| $3.97M | 0.03% |
53,183
+20,054
| +61% | +$1.55M |
|
429
CDW
CDW
$16.9B
| $3.95M | 0.03% |
22,124
+4,058
| +22% | +$713K |
|
430
Rivian
RIVN
$23.7B
| $3.9M | 0.03% |
211,471
+195,369
| +1,213% | +$5.75M |
|
|
SRNE
431
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $3.89M | 0.03% |
4,394,415
+1,399,741
| +47% | +$1.86M |
|
432
HP
HPQ
$26.6B
| $3.89M | 0.03% |
144,709
+23,101
| +19% | +$639K |
|
433
Enanta Pharmaceuticals
ENTA
$393M
| $3.88M | 0.03% |
83,414
+19,692
| +31% | +$898K |
|
434
Eaton
ETN
$178B
| $3.83M | 0.03% |
24,430
+11,748
| +93% | +$1.8M |
|
435
Agilent Technologies
A
$42.2B
| $3.81M | 0.03% |
25,465
+9,487
| +59% | +$1.35M |
|
436
Illinois Tool Works
ITW
$83.5B
| $3.79M | 0.03% |
17,205
+8,230
| +92% | +$1.75M |
|
437
Akamai
AKAM
$16.8B
| $3.77M | 0.03% |
44,775
+8,097
| +22% | +$705K |
|
438
Dollar General
DG
$26.5B
| $3.77M | 0.03% |
15,318
+5,800
| +61% | +$1.43M |
|
439
Cogent Biosciences
COGT
$6.61B
| $3.74M | 0.03% |
323,887
+114,511
| +55% | +$1.42M |
|
440
Coherus Oncology
CHRS
$187M
| $3.72M | 0.03% |
469,382
+200,546
| +75% | +$1.54M |
|
441
Par Pacific Holdings
PARR
$3.78B
| $3.71M | 0.03% |
159,693
+22,560
| +16% | +$491K |
|
442
Freeport-McMoran
FCX
$96.4B
| $3.7M | 0.03% |
97,446
+29,860
| +44% | +$1.04M |
|
443
Colgate-Palmolive
CL
$73.6B
| $3.68M | 0.03% |
46,650
+23,250
| +99% | +$1.74M |
|
444
Gevo
GEVO
$403M
| $3.67M | 0.03% |
1,933,515
+22,637
| +1% | +$47.8K |
|
445
Realty Income
O
$58.6B
| $3.63M | 0.03% |
57,184
+20,529
| +56% | +$1.27M |
|
446
Estee Lauder
EL
$31.8B
| $3.62M | 0.03% |
14,580
+6,147
| +73% | +$1.37M |
|
447
Waste Management
WM
$90.7B
| $3.6M | 0.03% |
22,979
+11,004
| +92% | +$1.77M |
|
448
EPAM Systems
EPAM
$5.15B
| $3.56M | 0.03% |
10,866
+1,675
| +18% | +$570K |
|
449
Invesco
IVZ
$13.8B
| $3.56M | 0.03% |
197,895
+13,629
| +7% | +$233K |
|
450
iShares MSCI Emerging Markets ETF
EEM
$29.9B
| $3.56M | 0.03% |
93,809
-85,170
| -48% | -$3.14M |
|
Similar funds
CS
JG
Rafferty Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, Rafferty Asset Management held 1,181 positions worth $11.9B, up 27% from $9.4B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Rafferty Asset Management deployed $1.81B of net new capital in Q4 2022, opening 44 new positions and adding to 774 existing holdings. Its largest new stake was Akero Therapeutics: 187,799 shares worth $10.3M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 38% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Microchip Technology, an estimated $12.3M trimmed.
- Rafferty Asset Management's largest Q4 2022 buy was Akero Therapeutics: 187,799 shares worth $10.3M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q4 2022, an estimated $294M increase.
- Rafferty Asset Management's biggest Q4 2022 reduction was Microchip Technology, cutting an estimated $12.3M.
- Rafferty Asset Management fully exited CONTINENTAL RESOURCES INC. in Q4 2022, selling an estimated $7.53M.
- Rafferty Asset Management's ten largest holdings make up 28% of its $11.9B portfolio in Q4 2022.
- Rafferty Asset Management opened 44 new positions and closed 61 in Q4 2022.
- Rafferty Asset Management's portfolio value rose 27% quarter-over-quarter to $11.9B.
Based on Rafferty Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.